Innovations in Controlled Release, Bioavailability & Continuous Mfg 2026

Now more than ever, the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the challenge of adherence, pharma and biotech need to innovative product development and delivery to improve therapeutic performance.

Now in it’s 13th successful year, the 2026 Summit on Innovations in Controlled Release, Bioavailability Enhancement and Continuous Manufacturing will provide you and your team this dose of innovation. Attendees learn directly from industry’s leading experts and hear multiple unique case study sessions and take-home examples to enhance their product pipelines. 2026’s Summit showcases the latest technologies and methods for improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.

Connect with 160+ senior drug development innovators in Princeton, NJ this May for industry’s leading drug product development Summit. Attend and and uncover industry’s latest formulation and delivery technologies for improving drug product performance and bioavailability. Benefit from 30+ expert sessions and panels

Are you looking to improve the performance of your drug products? Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions.